---
title: "Personalized multimodal lifestyle intervention for Alzheimer’s prevention in high‑risk older adults"
id: "medrxiv-0-clinical-and-attitudinal-outcomes-of-a-personalized-multimodal-lifestyle"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-clinical-and-attitudinal-outcomes-of-a-personalized-multimodal-lifestyle"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1?rss=1"
published_at: "2026-09-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Personalized multimodal lifestyle intervention for Alzheimer’s prevention in high‑risk older adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-clinical-and-attitudinal-outcomes-of-a-personalized-multimodal-lifestyle
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1?rss=1)
- **Published At:** 2026-09-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This pilot screened cognitively normal adults aged 65–75 in north Alabama for Alzheimer’s disease (AD) risk using family history, **APOE** genotyping, a non‑APOE polygenic risk score, and **plasma pTau217**. 138 individuals were screened and 52 (37.7%) met the study's high‑risk criteria. - High‑risk status was defined by a composite rubric: score >5 and/or **pTau217 >0.18 pg/mL**. Most high‑risk participants (69.2%) were classified by **pTau217** elevation alone. - High‑risk participants received disclosure of results and a 6‑month personalized, data‑driven **multimodal lifestyle intervention** including dietitian‑led coaching, cognitive training, and activity tracking. - Attitudes toward dementia risk and distress were measured before and after disclosure using survey instruments; objective cognition was assessed with the **MoCA**. Distress was measured with the **REVEAL IGT‑AD** scale. - Clinically significant distress scores appeared in 28% of respondents at one or more timepoints; half of these instances occurred in participants with pre‑existing anxiety or depression. - Over 6 months, **MoCA** scores and lifestyle risk indices were unchanged. **pTau217** continued to rise but at a slower rate compared with the pre‑intervention interval. - Self‑reported worry and perceived dementia risk decreased significantly after disclosure and during the intervention period, indicating improved attitudes despite limited short‑term biological change. - The study demonstrates feasibility of a genomics‑ and biomarker‑driven screening plus coaching model in a high‑risk, deep‑south cohort with manageable distress, supporting the need for larger, longer, and more diverse trials. - Trial registration: NCT07146412. Ethical approval: WCG Institutional Review Board (protocol #20250931). Data are available on reasonable request.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=fJ.lJ6qZUPNsqxuQuOycXiKAVSvJaIseQ.mTpMt4ptM-1790052398.3282113-1.2.1.1-qyPjKfqVV82KhBukcjcgcZ_c3LqFRC09X8P_xmherBXLk9tz0E_gg.CcTuyH8ymy) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Clinical and attitudinal outcomes of a personalized, multimodal lifestyle intervention for Alzheimer's disease prevention in high-risk, cognitively normal older adults in north Alabama: A pilot study Meagan Cochran, Jada Pugh, Tanner Coleman, Whitley Kelley, Paige Jamieson, Elizabeth Dunne, Patti Smith, Jessica Chasteen, Mary Jones, Jenny Turner, Halle Hurns, Gwendolyn Geissler, Mary Brunkow, Sydney Quinn Johnston, Katherine Metzger, Lena Seyfarth, Jared Taylor, Emily Shields, William Herrington, Wayne Schroer, Scott Newberry, Anna Hurst, James Yurkovich, Neil Lamb, Lee Hood, Simon Evans, Florencia Pauli Behn, Jennifer Lovejoy, Jesse Nicholas Cochran doi: https://doi.org/10.64898/2026.09.19.26363495 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Meagan Cochran 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Meagan%2BCochran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cochran%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMeagan%2BCochran%2B) Jada Pugh 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jada%2BPugh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pugh%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJada%2BPugh%2B) Tanner Coleman 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tanner%2BColeman%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Coleman%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATanner%2BColeman%2B) Whitley Kelley 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Whitley%2BKelley%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kelley%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWhitley%2BKelley%2B) Paige Jamieson 2 Phenome Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Paige%2BJamieson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jamieson%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APaige%2BJamieson%2B) Elizabeth Dunne 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elizabeth%2BDunne%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dunne%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElizabeth%2BDunne%2B) Patti Smith 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Patti%2BSmith%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Smith%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APatti%2BSmith%2B) Jessica Chasteen 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jessica%2BChasteen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chasteen%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJessica%2BChasteen%2B) Mary Jones 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mary%2BJones%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jones%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMary%2BJones%2B) Jenny Turner 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jenny%2BTurner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Turner%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJenny%2BTurner%2B) Halle Hurns 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Halle%2BHurns%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hurns%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHalle%2BHurns%2B) Gwendolyn Geissler 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gwendolyn%2BGeissler%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Geissler%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGwendolyn%2BGeissler%2B) Mary Brunkow 2 Phenome Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mary%2BBrunkow%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brunkow%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMary%2BBrunkow%2B) Sydney Quinn Johnston 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sydney%2BQuinn%2BJohnston%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Johnston%20SQ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASydney%2BQuinn%2BJohnston%2B) Katherine Metzger 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Katherine%2BMetzger%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Metzger%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKatherine%2BMetzger%2B) Lena Seyfarth 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lena%2BSeyfarth%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Seyfarth%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALena%2BSeyfarth%2B) Jared Taylor 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jared%2BTaylor%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Taylor%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJared%2BTaylor%2B) Emily Shields 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emily%2BShields%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shields%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmily%2BShields%2B) William Herrington 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=William%2BHerrington%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Herrington%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWilliam%2BHerrington%2B) Wayne Schroer 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Wayne%2BSchroer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schroer%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWayne%2BSchroer%2B) Scott Newberry 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Scott%2BNewberry%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Newberry%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AScott%2BNewberry%2B) Anna Hurst 3 Smith Family Clinic for Genomic Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BHurst%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hurst%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BHurst%2B) James Yurkovich 4 Buck Institute for Research on Aging * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=James%2BYurkovich%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yurkovich%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJames%2BYurkovich%2B) Neil Lamb 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Neil%2BLamb%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lamb%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANeil%2BLamb%2B) Lee Hood 2 Phenome Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lee%2BHood%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hood%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALee%2BHood%2B) Simon Evans 2 Phenome Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Simon%2BEvans%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Evans%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASimon%2BEvans%2B) Florencia Pauli Behn 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Florencia%2BPauli%2BBehn%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Behn%20FP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFlorencia%2BPauli%2BBehn%2B) Jennifer Lovejoy 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jennifer%2BLovejoy%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lovejoy%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJennifer%2BLovejoy%2B) Jesse Nicholas Cochran 1 HudsonAlpha Institute for Biotechnology; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jesse%2BNicholas%2BCochran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cochran%20JN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJesse%2BNicholas%2BCochran%2B) * For correspondence: ncochran@hudsonalpha.org * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1304773/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1304773/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1304773/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1304773/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.19.26363495v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1304773/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract INTRODUCTION: Multimodal lifestyle interventions can delay or slow Alzheimer's disease (AD) in at-risk older adults, and plasma pTau217, a blood-based biomarker, now enables scalable AD risk stratification. Population-level screening integrating genetic, biomarker, and lifestyle risk factors, alongside attitudes toward risk disclosure, remains understudied. This pilot assessed dementia-risk attitudes before and after disclosure and tested a personalized, data-driven multimodal coaching intervention in a high-risk Alabama population. METHODS: Cognitively normal adults aged 65-75 with a first-degree relative affected by AD/dementia were recruited in north Alabama and screened using the Montreal Cognitive Assessment, family history, APOE genotyping, non-APOE AD polygenic risk score, and plasma pTau217. A composite rubric classified high-risk status (score >5 and/or pTau217 >0.18 pg/mL); high-risk participants received results disclosure and a 6-month personalized intervention (dietitian-led coaching, cognitive training, activity tracking). Pre- and post-disclosure attitudes, distress (REVEAL IGT-AD scale), and biomarker/cognitive measures were assessed. RESULTS: Of 138 screened participants, 52 (37.7%) were high-risk, most (69.2%) by pTau217 alone. Before disclosure, subjective dementia-risk perception correlated with objective risk score. Scores consistent with post-disclosure clinically significant distress occurred in 28% of survey respondents in at least one timepoint but was often (50%) observed with pre-existing anxiety/depression. Over 6 months, MoCA scores and lifestyle risk indices were unchanged, pTau217 continued rising but at a slowed rate compared to between screening and the beginning of the lifestyle intervention, and self-reported worry and perceived dementia risk decreased significantly. DISCUSSION: A genomics- and biomarker-informed screening and coaching model is feasible in a high-risk cohort in the deep south, with manageable distress and improved attitudes despite limited short-term biological change. Findings support larger, longer, and more diverse trials validating this approach for AD screening. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial NCT07146412 ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: WCG Institutional Review Board gave ethical approval for this work (protocol #20250931). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with a
## Related Clinical Research

- [Carbon monoxide exposure may explain lower Parkinson's risk linked to smoking](https://medichelpline.com/clinical-feed/medical-news-today-0-why-smokers-may-have-a-lower-parkinson-s-risk-it-s-not-the-nicotine.md)
- [Memory decline may begin in middle age due to hippocampal changes, study finds](https://medichelpline.com/clinical-feed/medical-news-today-0-memory-decline-may-begin-as-early-as-middle-age-a-new-study-suggests.md)
- [eSMARTER trial: Digital versus Clinician-Mediated Return of APOE and pTau-217 Results](https://medichelpline.com/clinical-feed/medrxiv-8-returning-apoe-and-ptau-217-results-the-esmarter-randomized-noninferiority.md)
- [Genetic Ancestry Versus Self-Reported Race Alters Neuropsychiatric Symptom Estimates in Alzheimer'](https://medichelpline.com/clinical-feed/medrxiv-21-discordance-between-genetic-ancestry-and-self-reported-race-impacts-inference.md)
- [Data-driven hearing rehabilitation versus standard care trial: protocol for older adults with hear](https://medichelpline.com/clinical-feed/bmj-open-19-proof-of-concept-randomised-controlled-trial-of-data-driven-hearing.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.